Hesham Abdullah: key facts
- Kind of voice
- Sector leader
- Role
- GSK's global head of cancer research and development
- Quoted on
- Cancer
- Tracked press citations
- 1
- Most recently quoted
- 27 Aug 2026
“Treatment of gynaecological cancers remains a major challenge, with a pressing need for new therapies that offer improved response rates. With Mo-Rez we now have compelling evidence of a promising clinical profile.”
Where Hesham Abdullah has been quoted
- GSK reports promising early results in ovarian and womb cancer drug trialtheguardian.com · 27 Aug 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.